Option Care Health, Inc. (OPCH), founded in 1979 and headquartered in Bannockburn, Illinois, is the nation's largest independent provider of home and alternate treatment site infusion services. As a publicly traded company on NASDAQ under the stock symbol OPCH, the company has grown significantly since its inception, now with a vast network covering the entire United States.
Serving patients across all 50 states through over 125 local service locations, Option Care Health has a dedicated workforce of approximately 2,900+ compounding pharmacists, registered nurses, and dietitians who work directly with patients, physicians, hospitals, and health care services providers. This allows patients to receive comprehensive clinical care in the comfort of their own homes or any other convenient location.
Option Care Health offers a wide range of therapies, including anti-infective, nutritional, chronic, cardiopulmonary, and bleeding disorder therapies. More importantly, they have a specialty in a variety of diseases such as multiple sclerosis, rheumatoid arthritis, hemophilia, immune deficiencies, and more, offering customized care plans for these patients.
Guided by a strong commitment to quality and patient-centric care, Option Care Health ensures that patients receive the right medication, at the right time, in the right dose, and via the right route. They employ a multidisciplinary team approach to patient care, involving pharmacists, nurses, and dietitians who collaborate to manage the treatment in an effective and efficient manner.
Furthermore, Option Care Health fosters partnerships with leading pharmaceutical manufacturers and distributors, hospitals, healthcare systems, and insurance providers. These partnerships are instrumental in establishing robust treatment plans addressing the unique needs of each patient.
The company notes a high level of patient satisfaction, showcasing a series of productive outcomes and benefits for patients, such as fewer hospital visits, minimized re-hospitalizations, increased medication adherence, improved quality of life, and reduced overall healthcare costs post-intervention.
In terms of revenue, Option Care Health reported impressive numbers in 2020, despite the ongoing pandemic. This shows the resilience of the organization and the ever-increasing demand for home and alternate treatment site services across the nation.
Drawing from its over forty years of experience in the market, Option Care Health is well-positioned to continue leading and innovating in the home infusion services sector. Undoubtedly, Option Care Health, Inc. (OPCH) is a significant stakeholder in rendering complex clinical care more accessible, cost-effective, and patient-centric.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
This article identifies three healthcare stocks—Option Care Health (OPCH), Illumina (ILMN), and Merck (MRK)—that StockStory advises investors to approach with caution despite the healthcare industry's recent strong performance. The warnings are based on issues such as slowing sales growth, stagnant free cash flow, negative returns on capital, underwhelming revenue performance, and increasing expenses relative to revenue for these companies. The article suggests readers review detailed reports for a full understanding of these concerns.
This article from Stock Traders Daily discusses technical reactions to Option Care Health Inc. (NASDAQ: OPCH) trends, highlighting a stable neutral reading in shorter horizons that could indicate an easing of a long-term weak bias. It details three AI-generated institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, along with a multi-timeframe signal analysis. The analysis also points to an exceptional 73.3:1 risk-reward setup targeting a significant gain with minimal risk.
Option Care Health, Inc. (OPCH) is a significant player in home and alternate site infusion services with a market cap of $3.64 billion. The company, currently trading at $24.30, has a positive outlook from analysts, with an average target price of $28.58 indicating a 17.63% upside potential. Despite not paying dividends, its strong free cash flow and strategic focus on growing healthcare demands position it as an attractive investment for growth-oriented investors.
Squarepoint Ops LLC significantly increased its stake in Option Care Health (NASDAQ:OPCH) during the second quarter, adding 304,376 shares to own a total of 434,408 shares valued at $9.1 million. This increase comes as Option Care Health exceeded quarterly earnings expectations with $0.45 adjusted EPS and $1.44 billion in revenue. Despite mixed analyst sentiment and some downgrades, a significant portion of the stock remains owned by hedge funds and institutional investors.
Option Care Health, Inc. (NASDAQ:OPCH) has received a consensus "Hold" rating from fourteen brokerages, with an average 12-month price target of $29.92. The company recently surpassed quarterly earnings and revenue expectations, reporting $0.45 EPS and $1.44 billion in revenue. Institutional investors hold a significant 98.05% of the company's outstanding shares.
Paralel Advisors LLC has acquired a new stake in Option Care Health, Inc. (NASDAQ:OPCH), purchasing 85,835 shares valued at approximately $1.8 million in the second quarter. This move is part of broader institutional investor activity, with 98.05% of the company's stock owned by institutional investors and hedge funds. Despite mixed analyst ratings, Option Care Health exceeded quarterly earnings expectations, reporting $0.45 EPS and $1.44 billion in revenue.
Raiffeisen Bank International AG significantly increased its stake in Option Care Health, Inc. by purchasing an additional 120,000 shares, bringing their total ownership to 250,000 shares valued at approximately $5.33 million. This move comes as Option Care Health has shown strong earnings, beating analysts' expectations, while its stock trades below its 52-week high. Analysts currently have a consensus "Hold" rating for the company with an average price target of $29.92.
This article analyzes Q2 earnings for senior health, home health, and hospice stocks, highlighting Option Care Health (OPCH) and its peers. Option Care Health reported strong Q2 results with revenues up 1.9% year-on-year, exceeding expectations. The broader industry faces challenges from labor costs and regulatory uncertainty but is poised for growth due to an aging population and increasing demand for in-home care.